AYUSH Minister inaugurates International forum for Advancing Global Collaboration in Homoeopathy Medicines
Homoeopathic Pharmacopoeia Laboratory and a work force of about 250 thousand homoeopathic clinicians, India can contribute in various aspects of mainstream healthcare.
New Delhi: The World Integrated Medicine Forum on the regulation of Homoeopathic Medicinal Products with the theme ‘Advancing Global Collaboration’ was inaugurated today by Shri Sripad Naik, Union Minister of State (I/C), Ministry of AYUSH. The three-day forum is being organised by Central Council for Research in Homeopathy (CCRH), with the support of Ministry of AYUSH, Homoeopathic Pharmacopoeia Convention of the United States (HPCUS) and European Coalition on Homeopathic & Anthroposophic Medicinal Products (ECHAMP), Pharmacopoeia Commission of Indian Medicine and Homoeopathy and Central Drugs Standard Control Organization (CDSCO).
The forum has participation of key public and private sector stakeholders, such as representatives from World Health Organisation (WHO) and drug regulatory authorities, as well as pharmacopoeia experts and industrialists from countries like Germany, USA, France, UK, Brazil, Belgium, South Africa, Argentina, Russia, Greece, Austria, Cuba, Qatar, Croatia, Malaysia, Japan, Hongkong and Sri Lanka. Among the delegates are also present veterinary experts, as well as the regulators and drug controllers of various states of India.
More than a billion patients worldwide are demanding safe and effective medicines for their healthcare. As a result, the demand for Homoeopathy is growing. There is still a highly disparate situation among countries with regard to the regulations of homeopathic medicines and this directly affects the availability of these medicines.
Apart from illustrating how homeopathy can be further regulated and integrated into the healthcare system in countries that have adopted the use of Homoeopathy since long, this Forum will also bring countries to the table where homeopathy has only been recently introduced.
Forum discussions will primarily explore the commonalities as well as differences in regulatory affairs among various countries, discuss strategic regulatory and industry perspectives and possible scenarios in advancing international collaboration, ways to further enhance pharmaceutical quality standards, deliberate on integrating Traditional Medicine systems in primary healthcare and public health, bring forth the perspectives on setting appropriate requirements on various dimensions of drug approvals including veterinary medicine.
While appreciating the efforts for organising this forum, Shri Shirpad Naik in his inaugural address remarked that India is the fifth largest investor in scientific research in Homoeopathy in the world. With the institutional support of more than 200 homoeopathic colleges and an autonomous Research Council having 26 research centres, Homoeopathic Pharmacopoeia Laboratory and a work force of about 250 thousand homoeopathic clinicians, India can contribute in various aspects of mainstream healthcare.
He called upon the industry as well as homoeopathic medical colleges to invest certain percentage of institutional and industrial revenues in research and collaborate with CCRH for undertaking high quality, cutting edge research projects.
